The purpose of our study was to describe ultra-widefield (UWF) imaging and optical coherence tomography angiography (OCT-A) findings in affected and fellow eyes of patients with Coats’ disease.
Consecutive patients affected by Coats’ disease were prospectively recruited at the Department of Ophthalmology, San Raffaele Hospital, Milan, Italy in this cross-sectional, observational study. Patients underwent UWF color fundus photographs, UWF green autofluorescence, UWF fluorescein angiography (FA), optical coherence tomography (OCT), with 3 × 3 mm and 6 × 6 mm OCT-A scans of the macula. Images were qualitatively evaluated by two independent operators for the presence of pathology.
Eleven patients affected by Coats’ disease (eight males, mean age 17.1 ± 6.7 years). Nine and two patients had a clinical diagnosis of unilateral and bilateral disease, respectively. Five eyes had macular fibrosis. All clinically affected eyes exhibited retinal pathology at UWF imaging with the temporal sector most involved followed by the inferior, nasal, superior and macula. In all eyes with macular fibrosis, OCT-A revealed replacement of the foveal avascular zone with coarse vessels suggestive of vascularized fibrosis and flow void area in the choriocapillaris due to a masking effect; type 3 neovascularization was seen in 75% of cases. Seven out of nine clinically unaffected fellow eyes showed retinal pathology at UWF FA with the temporal quadrant most involved.
We demonstrated that Coats’ disease is a highly asymmetric bilateral disease and that UWF imaging is able to identify more retinal pathology than standard fundus imaging, thus guiding proper retinal photocoagulation. OCT-A allowed easy identification of type 3 neovascularization in a proportion of patients with macular fibrosis.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Shields JA, Shields CL (2002) Review: coats disease: the 2001 LuEsther T. Mertz lecture. Retina 22:80–91
Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of coats disease in 150 cases: the 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561–571
Witmer MT, Kiss S (2013) Wide-field imaging of the retina. Surv Ophthalmol 58:143–154. https://doi.org/10.1016/j.survophthal.2012.07.003
Singer M, Sagong M, van Hemert J, Kuehlewein L, Bell D, Sadda SR (2016) Ultra-widefield imaging of the peripheral retinal vasculature in normal subjects. Ophthalmology 123:1053–1059. https://doi.org/10.1016/j.ophtha.2016.01.022
Kang KB, Wessel MM, Tong J, D'Amico DJ, Chan RV (2013) Ultra-widefield imaging for the management of pediatric retinal diseases. J Pediatr Ophthalmol Strabismus 50:282–288. https://doi.org/10.3928/01913913-20130528-04
Kumar V, Chandra P, Kumar A (2017) Ultra-wide field imaging in the diagnosis and management of adult-onset Coats' disease. Clin Exp Optom 100:79–82. https://doi.org/10.1111/cxo.12418
Rabiolo A, Carnevali A, Bandello F, Querques G (2016) Optical coherence tomography angiography: evolution or revolution? Expert Rev Ophthalmol 11:243–245
Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ (2015) Pearls and pitfalls in diagnosis and management of coats disease. Retina 35:614–623. https://doi.org/10.1097/IAE.0000000000000485
Shields JA, Shields CL, Honavar SG, Demirci H, Cater J (2001) Classification and management of coats disease: the 2000 proctor lecture. Am J Ophthalmol 131:572–583
Daruich AL, Moulin AL, Tran HV, Matet A, Munier FL (2016) SUBFOVEAL NODULE IN COATS' DISEASE: toward an updated classification predicting visual prognosis. Retina. https://doi.org/10.1097/IAE.0000000000001399
Blair MP, Ulrich JN, Elizabeth Hartnett M, Shapiro MJ (2013) Peripheral retinal nonperfusion in fellow eyes in coats disease. Retina 33:1694–1699. https://doi.org/10.1097/IAE.0b013e318285cb86
Kaneko Y, Moriyama M, Hirahara S, Ogura Y, Ohno-Matsui K (2014) Areas of nonperfusion in peripheral retina of eyes with pathologic myopia detected by ultra-widefield fluorescein angiography. Invest Ophthalmol Vis Sci 55:1432–1439. https://doi.org/10.1167/iovs.13-13706
Tsui I, Bajwa A, Franco-Cardenas V, Pan CK, Kim HY, Schwartz SD (2013) Peripheral fluorescein angiographic findings in fellow eyes of patients with branch retinal vein occlusion. Int J Inflamm 2013:464127. https://doi.org/10.1155/2013/464127
Oliver SC, Schwartz SD (2010) Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography. Semin Ophthalmol 25:27–33. https://doi.org/10.3109/08820538.2010.481239
Dodo Y, Murakami T, Unoki N, Ogino K, Uji A, Yoshitake S, Yoshimura N (2016) White dots as a novel marker of diabetic retinopathy severity in ultrawide field imaging. PLoS One 11:e0165906. https://doi.org/10.1371/journal.pone.0165906
Lu J, Mai G, Luo Y, Li M, Cao D, Wang X, Yan H, Sadda SR, Lu L (2017) Appearance of far peripheral retina in normal eyes by ultra-widefield fluorescein angiography. Am J Ophthalmol 173:84–90. https://doi.org/10.1016/j.ajo.2016.09.024
Shah AR, Abbey AM, Yonekawa Y, Khandan S, Wolfe JD, Trese MT, Williams GA, Capone A Jr (2016) Widefield fluorescein angiography in patients without peripheral disease: a study of normal peripheral findings. Retina 36:1087–1092. https://doi.org/10.1097/IAE.0000000000000878
Black GC, Perveen R, Bonshek R, Cahill M, Clayton-Smith J, Lloyd IC, McLeod D (1999) Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet 8:2031–2035
Gilmour DF (2015) Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond) 29:1–14. https://doi.org/10.1038/eye.2014.70
Holmstrom G, Thoren K (2000) Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand 78:348–353
Yonekawa Y, Todorich B, Trese MT (2016) Optical coherence tomography angiography findings in Coats' disease. Ophthalmology 123:1964. https://doi.org/10.1016/j.ophtha.2016.05.004
Hautz W, Golebiewska J, Kocyla-Karczmarewicz B (2017) Optical coherence tomography and optical coherence tomography angiography in monitoring Coats' disease. J Ophthalmol 2017:7849243. https://doi.org/10.1155/2017/7849243
Muakkassa NW, de Carlo TE, Choudhry N, Duker JS, Baumal CR (2016) Optical coherence tomography angiography findings in Coats' disease. Ophthalmic Surg Lasers Imaging Retina 47:632–635. https://doi.org/10.3928/23258160-20160707-04
Cicinelli MV, Carnevali A, Rabiolo A, Querques L, Zucchiatti I, Scorcia V, Bandello F, Querques G (2017) Clinical spectrum of macular-foveal capillaries evaluated with optical coherence tomography angiography. Retina 37:436–443. https://doi.org/10.1097/IAE.0000000000001199
Yeung J, Crock G, Cairns J, Heinze J, Troski S, Billson F (1973) Macular-foveal capillaries in human retina. Aust J Ophthalmol 1:17–23
Jumper JM, Pomerleau D, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2010) Macular fibrosis in coats disease. Retina 30:S9–14
Sigler EJ, Calzada JI (2015) Retinal angiomatous proliferation with chorioretinal anastomosis in childhood coats disease: a reappraisal of macular fibrosis using multimodal imaging. Retina 35:537–546. https://doi.org/10.1097/IAE.0000000000000341
Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG (2014) Current management of coats disease. Surv Ophthalmol 59:30–46. https://doi.org/10.1016/j.survophthal.2013.03.007
Prof Giuseppe Querques and Prof Francesco Bandello have contributed equally to this study and should be considered as equivalent authors.
Conflict of interest
Alessandro Rabiolo, Alessandro Marchese, Riccardo Sacconi, Maria Vittoria Cicinelli, Andrea Grosso and Lea Querques have no disclosures. Giuseppe Querques is a consultant for: Alimera Sciences (Alpharetta, GA, USA), Allergan Inc. (Irvine, CA, USA), Bayer Schering-Pharma (Berlin, Germany), Heidelberg (Germany), Novartis (Basel, Switzerland), Sandoz (Berlin, Germany), Zeiss (Dublin, CA, USA). Francesco Bandello has the following disclosures: ALLERGAN (S), ALIMERA (S), BAYER (S), FARMILA-THEA (S), SCHERING PHARMA (S), SANOFI-AVENTIS (S), NOVAGALI (S), PHARMA (S), HOFFMANN-LA ROCHE (S), GENENTECH (S), and NOVARTIS (S).
About this article
Cite this article
Rabiolo, A., Marchese, A., Sacconi, R. et al. Refining Coats’ disease by ultra-widefield imaging and optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol 255, 1881–1890 (2017). https://doi.org/10.1007/s00417-017-3794-7
- Coats’ disease
- Macular fibrosis
- Ultra-widefield imaging
- Ultra-widefield fluorescein angiography
- Optical coherence tomography angiography
- Optical coherence tomography